FMR LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 67 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 1.4%.

Quarter-by-quarter ownership
FMR LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$288,000
-25.4%
90,310
-0.1%
0.00%
Q1 2022$386,000
+9550.0%
90,441
+8944.1%
0.00%
Q3 2021$4,000
+100.0%
1,000
+100.0%
0.00%
Q2 2021$2,000500
+861.5%
0.00%
Q4 2020$0
-100.0%
52
-99.8%
0.00%
Q3 2020$107,000
-75.1%
26,485
-73.8%
0.00%
Q2 2020$430,000
-91.8%
100,985
-92.0%
0.00%
-100.0%
Q1 2020$5,271,000
+6.9%
1,254,989
-0.0%
0.00%0.0%
Q4 2019$4,932,000
-86.2%
1,255,018
-69.1%
0.00%
-75.0%
Q3 2019$35,770,000
-4.9%
4,064,8160.0%0.00%0.0%
Q2 2019$37,599,000
+44.0%
4,064,816
+0.1%
0.00%
+33.3%
Q1 2019$26,115,000
-29.6%
4,061,425
+3.3%
0.00%
-40.0%
Q4 2018$37,091,000
-53.2%
3,933,351
-0.0%
0.01%
-44.4%
Q3 2018$79,184,000
-25.8%
3,933,641
+7.5%
0.01%
-25.0%
Q2 2018$106,694,000
-0.6%
3,657,684
+1.5%
0.01%
-7.7%
Q1 2018$107,288,000
+0.4%
3,602,698
+8.5%
0.01%0.0%
Q4 2017$106,895,000
-7.4%
3,321,786
+0.1%
0.01%
-7.1%
Q3 2017$115,418,000
+17.0%
3,318,518
+0.2%
0.01%
+16.7%
Q2 2017$98,637,000
+0.3%
3,313,318
+0.6%
0.01%0.0%
Q1 2017$98,339,000
+104.9%
3,294,435
+20.3%
0.01%
+100.0%
Q4 2016$47,999,000
-26.3%
2,738,1010.0%0.01%
-33.3%
Q3 2016$65,139,000
+55.4%
2,738,101
+4.5%
0.01%
+50.0%
Q2 2016$41,925,000
-24.5%
2,620,326
-1.3%
0.01%
-25.0%
Q1 2016$55,509,000
-24.9%
2,654,659
-3.0%
0.01%
-20.0%
Q4 2015$73,878,000
-0.4%
2,736,226
+2.5%
0.01%
-9.1%
Q3 2015$74,203,000
+32.3%
2,670,126
+16.7%
0.01%
+57.1%
Q2 2015$56,070,000
+60.7%
2,287,626
+20.0%
0.01%
+75.0%
Q1 2015$34,883,000
+70.8%
1,906,167
+72.2%
0.00%
+33.3%
Q4 2014$20,418,000
+92.0%
1,106,6410.0%0.00%
+200.0%
Q3 2014$10,635,000
+140.6%
1,106,641
+129.8%
0.00%0.0%
Q2 2014$4,421,000
+91.6%
481,641
+125.5%
0.00%
Q1 2014$2,307,000213,5730.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders